Showing results (561-570 of 5,813) with videos related to
Sort By:
Pageof 582
Drug Design, Development and Therapy|September 24, 2015
Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic reviewAleksandra Kotlinska-Lemieszek, Pål Klepstad, Dagny Faksvåg HaugenDrug Design, Development and Therapy|September 11, 2015
Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regimeQiao Lai, Jiabao Wei, Mohammed Mahmoodurrahman, et al.Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.Drug Design, Development and Therapy|October 28, 2015
Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's diseaseShreesh Ojha, Hayate Javed, Sheikh Azimullah, et al.Drug Design, Development and Therapy|October 29, 2015
Urinary kallidinogenase for the treatment of cerebral arterial stenosisLiandong Zhao, Ying Zhao, Qi Wan, et al.Drug Design, Development and Therapy|October 29, 2015
Development of PPAR-agonist GW0742 as antidiabetic drug: study in animalsHo-Shan Niu, Po-Ming Ku, Chiang-Shan Niu, et al.Drug Design, Development and Therapy|January 22, 2016
Isolation and evaluation of biological efficacy of quercetol in human hepatic carcinoma cellsHuma Ali, Savita Dixit, Daoud Ali, et al.Drug Design, Development and Therapy|January 22, 2016
Baicalein attenuates the quorum sensing-controlled virulence factors of Pseudomonas aeruginosa and relieves the inflammatory response in P. aeruginosa-infected macrophages by downregulating the MAPK and NFκB signal-transduction pathwaysJing Luo, Jin-Liang Kong, Bi-Ying Dong, et al.Drug Design, Development and Therapy|February 3, 2016
Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trialsNarong Maneeton, Benchalak Maneeton, Pakapan Woottiluk, et al.Drug Design, Development and Therapy|March 2, 2016
Drug-loaded erythrocytes: on the road toward marketing approvalVanessa Bourgeaux, José M Lanao, Bridget E Bax, et al.Pageof 582